CHONGQING, CHINA - MAY 04: In this photo illustration, the logo of Hims & Hers Health, Inc. is displayed on a smartphone screen, with the company's stock market performance and candlestick chart ...
Hims & Hers stock (NYSE: HIMS) increased by 16% yesterday following its announcement about expanding into the treatment of menopause and perimenopause—a strategic shift indicating that the company is ...
Hims & Hers Health Stock Slides on Earnings Miss and Soft Guidance: Is $40 the Next Stop? Hims & Hers Health (HIMS) reported Q2 results after the close last night, delivering a mixed set of numbers ...
Hims & Hers Health Inc (NYSE:HIMS) investors can’t catch a break. Less than two months since Novo Nordisk AS (NYSE:NVO) terminated its Wegovy partnership with the telehealth company abruptly, the ...
Hims & Hers Health, Inc. (NYSE:HIMS) has seen a surge in retail investor interest, which positions it as one of the most high-profile candidates for the next “meme stock” rally. Hims & Hers stock has ...
Novo Nordisk's partnership termination and legal risks threaten HIMS's core compounded weight loss drug business, raising significant regulatory uncertainty. HIMS's high valuation is no longer ...
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, positions itself as a consumer-first health and wellness platform, designed to transform the way individuals access and manage ...
The telehealth revolution that transformed how millions of Americans access healthcare is facing a reality check, as one of the industry’s most prominent companies grapples with the challenge of ...
LONDON, Aug 11 (Reuters) - In Novo Nordisk’s (NOVOb.CO), opens new tab legal fight against dozens of U.S. pharmacies and companies selling cheaper copies of its weight-loss drug Wegovy, one name ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback